Literature DB >> 2688755

Granulocyte-macrophage colony-stimulating factor binding sites and oxidative metabolism in human granulocytes.

M Häder1, M Klausmann, K H Pflüger, G Lüben, F R Seiler, K Havemann.   

Abstract

We investigated the interaction between GM-CSF and its receptor on human granulocytes and on several human tumor cell lines. Specific high-affinity binding for GM-CSF was characterized by Scatchard plot analysis. The specific radioactivity of the 125I-labeled derivative of rH. GM-CSF was determined by self-displacement analysis and calculated to be 30 microCi/micrograms. The maximum concentration of binding sites (B max) in granulocytes was 40 fmol/mg protein (2,200 molecules GM-CSF bound/cell) and the dissociation constant (KD) was 0.42 nM. No binding sites for GM-CSF were found in two lung cancer cell lines, SCLC-16HV and NCI-N417 or in the urinary bladder carcinoma cell line 5637, whereas the promyelocytic leukemia cell line HL60 was positive for GM-CSF binding. Time course experiments showed maximum binding of GM-CSF in granulocytes after an incubation period of 60 min and a decrease in binding after an incubation period of 2 h. In parallel, we found a maximum biological signal when granulocytes were preincubated for 90 min with GM-CSF, and a decrease after an incubation time of 120 min. Preincubation of the cells with rH. GM-CSF induced an enhancement of the production of activated oxygen species by the cells in response to PMA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688755     DOI: 10.1007/bf00329493

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  28 in total

Review 1.  The granulocyte-macrophage colony stimulating factors.

Authors:  D Metcalf
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

2.  Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.

Authors:  K H Grabstein; D L Urdal; R J Tushinski; D Y Mochizuki; V L Price; M A Cantrell; S Gillis; P J Conlon
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

3.  Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.

Authors:  M A Vadas; N A Nicola; D Metcalf
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

4.  Iodination of biological samples without loss of functional activity.

Authors:  F Tejedor; J P Ballesta
Journal:  Anal Biochem       Date:  1982-11-15       Impact factor: 3.365

5.  Stimulation of oxidative metabolism of granulocytes by recombinant granulocyte-macrophage-colony-stimulating-factor and a conditioned medium of a urinary bladder carcinoma cell line.

Authors:  M Klausmann; K H Pflüger; D Krumwieh; F R Seiler; K Havemann
Journal:  Blut       Date:  1987-05

6.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator.

Authors:  R H Weisbart; D W Golde; S C Clark; G G Wong; J C Gasson
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

7.  High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells.

Authors:  J C Gasson; S E Kaufman; R H Weisbart; M Tomonaga; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637.

Authors:  J L Gabrilove; K Welte; P Harris; E Platzer; L Lu; E Levi; R Mertelsmann; M A Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  Release of spleen focus-forming virus (SFFV) from differentiation inducible promyelocytic leukemia cell lines transformed in vitro by Friend leukemia virus.

Authors:  J S Greenberger; R J Eckner; W Ostertag; G Colletta; S Boschetti; H Nagasawa; A Karpas; R R Weichselbaum; W C Moloney
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

10.  Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor.

Authors:  L S Park; D Friend; S Gillis; D L Urdal
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.